Aussie race to market kicks off for obesity pills
The race to launch the first once-daily oral GLP-1 weight loss drug in Australia has officially begun after the TGA approved Novo's Wegovy, with the company confirming it could hit the market this year.
To see the whole article, log in or create an account.